Study Points to the Need for More Access to Innovative Medicines in Rare Disease
4 Articles
4 Articles
The study, which mapped 377 patients nationally, revealed that almost half of patients (46%) who are taking preventive treatment continue to be treated with "androgens attenuated", associated with multiple side effects
A study on hereditary angioedema, a rare disease that can be fatal and affects more than 350 people in Portugal, concludes by the need to give more access to innovative medicines, to reduce the side effects, especially cardiometabolic. In statements to Lusaka, Manuel Branco Ferreira, immunoallergologist of the Local Health Unit of Santa Maria, in Lisbon, and coordinator of the first and most comprehensive portrait of the disease in Portugal, exp…
A national study shows that almost half of patients with hereditary angioedema who undergo preventive treatment continue to receive old medicines, associated with serious side effects. Access to innovative therapies is more limited in smaller hospitals.
Hereditary angioedema is a genetic and rare disease characterized by recurrent episodes of severe and deep swelling in the skin, mucous membranes and internal organs.
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium








